<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31965725</PMID><DateCompleted><Year>2021</Year><Month>02</Month><Day>01</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1752-699X</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>5</Issue><PubDate><Year>2020</Year><Month>May</Month></PubDate></JournalIssue><Title>The clinical respiratory journal</Title><ISOAbbreviation>Clin Respir J</ISOAbbreviation></Journal><ArticleTitle>Outcome of status asthmaticus at a pediatric intensive care unit in Hong Kong.</ArticleTitle><Pagination><StartPage>462</StartPage><EndPage>470</EndPage><MedlinePgn>462-470</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/crj.13154</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To characterize the clinical course and outcome of children with status asthmaticus (SA) admitted to a pediatric intensive care unit (PICU) METHODS: All patients with SA who were admitted to a PICU from January 2003 to December 2018 were reviewed. Polymerase chain reaction (PCR) studies on nasopharyngeal aspirate for respiratory pathogens were performed from 2014 to 2018.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Sixty-seven SA admissions constituted 2.4% of total PICU admissions (n&#xa0;=&#xa0;2788). Fifteen (22.4%) children required noninvasive ventilation (NIV), while 7 children (10%) required invasive mechanical ventilation. Nonadherence to prior asthma therapy was common. PCR was positive for enterorvirus/rhinovirus in 84% (16 out of 19) and for any virus in 95% of nasopharyngeal aspirate (NPA) samples of patients between 2014 and 2018. Over the 16-year period, increased utilization of ipratropium bromide, magnesium sulfate and NIV was noted (P&#xa0;&lt;&#xa0;.05). Patients who required invasive mechanical ventilation had significantly higher heart rate, lower pH and longer PICU length of stay (LOS) when compared to nonintubated children (P&#xa0;&lt;&#xa0;.05). There was no mortality, gender difference, or seasonal characteristics in these SA admissions. Median LOS in PICU was 2 days (interquartile range 1-3 days).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">SA accounts for a small proportion of PICU admissions. LOS was short and prognosis generally good. Nonadherence to prior asthma therapy was common. The most common trigger is enterovirus/rhinovirus for children with severe asthma requiring PICU admission. A trend of increase in usage of ipratropium, magnesium sulfate and NIV was observed. Primary prevention and early treatment of exacerbation are the most important step in managing children with asthma. Regular follow-up to ensure compliance together with annual vaccination could possibly avoid PICU admissions.</AbstractText><CopyrightInformation>&#xa9; 2020 John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Wing Tak</ForeName><Initials>WT</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Department of Paediatrics, The Chinese University of Hong Kong, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hon</LastName><ForeName>Kam Lun</ForeName><Initials>KL</Initials><Identifier Source="ORCID">0000-0002-6682-5529</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, Department of Paediatrics, The Chinese University of Hong Kong, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Renee W Y</ForeName><Initials>RWY</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Department of Paediatrics, The Chinese University of Hong Kong, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Lawrence C N</ForeName><Initials>LCN</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Department of Paediatrics, The Chinese University of Hong Kong, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>William</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Cheung</LastName><ForeName>Hon Ming</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, Prince of Wales Hospital Ringgold Standard Institution, New Territories, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qian</LastName><ForeName>Su Yun</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Pediatric Intensive Care Unit, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>02</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Clin Respir J</MedlineTA><NlmUniqueID>101315570</NlmUniqueID><ISSNLinking>1752-6981</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000927">Anticonvulsants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001993">Bronchodilator Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>7487-88-9</RegistryNumber><NameOfSubstance UI="D008278">Magnesium Sulfate</NameOfSubstance></Chemical><Chemical><RegistryNumber>GR88G0I6UL</RegistryNumber><NameOfSubstance UI="D009241">Ipratropium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000927" MajorTopicYN="N">Anticonvulsants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001249" MajorTopicYN="N">Asthma</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001993" MajorTopicYN="N">Bronchodilator Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006723" MajorTopicYN="N" Type="Geographic">Hong Kong</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015278" MajorTopicYN="N">Intensive Care Units, Pediatric</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009241" MajorTopicYN="N">Ipratropium</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008278" MajorTopicYN="N">Magnesium Sulfate</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055118" MajorTopicYN="N">Medication Adherence</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009305" MajorTopicYN="N">Nasopharynx</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D063087" MajorTopicYN="N">Noninvasive Ventilation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012229" MajorTopicYN="N">Rhinovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013224" MajorTopicYN="N">Status Asthmaticus</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Hong Kong</Keyword><Keyword MajorTopicYN="N">PICU</Keyword><Keyword MajorTopicYN="N">asthma</Keyword><Keyword MajorTopicYN="N">children</Keyword><Keyword MajorTopicYN="N">critical care</Keyword><Keyword MajorTopicYN="N">pediatric</Keyword><Keyword MajorTopicYN="N">status asthmaticus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>7</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>9</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>1</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31965725</ArticleId><ArticleId IdType="doi">10.1111/crj.13154</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Wong GWK, Leung TF, Ko FWS. Changing prevalence of allergic diseases in the Asia-Pacific region. Allergy Asthma Immunol Res. 2013;5(5):251-257.</Citation></Reference><Reference><Citation>Hon K-L, Nelson EAS. Gender disparity in paediatric hospital admissions. Ann Acad Med Singapore. 2006;35(12):882-888.</Citation></Reference><Reference><Citation>Hon K-L, Tang W-S, Leung T-F, Cheung K-L, Ng P-C. Outcome of children with life-threatening asthma necessitating pediatric intensive care. Ital J Pediatr. 2010;36(1):47.</Citation></Reference><Reference><Citation>Hon KLE, Leung AKC. Medications and recent patents for status asthmaticus in children. Recent Pat Inflamm Allergy Drug Discov. 2017;11(1):12-21.</Citation></Reference><Reference><Citation>Werner HA. Status asthmaticus in children: a review. Chest. 2001;119(6):1913-1929.</Citation></Reference><Reference><Citation>Schivo M, Phan C, Louie S, Harper RW. Critical asthma syndrome in the ICU. Clin Rev Allergy Immunol. 2015;48(1):31-44.</Citation></Reference><Reference><Citation>Papadopoulos NG, Arakawa H, Carlsen KH, et al. International consensus on (ICON) pediatric asthma. Allergy Eur J Allergy Clin Immunol. 2012;67(8):976-997.</Citation></Reference><Reference><Citation>Tesse R, Borrelli G, Mongelli G, Mastrorilli V, Cardinale F. Treating pediatric asthma according guidelines. Front Pediatr. 2018;6:234.</Citation></Reference><Reference><Citation>British Thoracic Society, Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. Thorax. 2014;69(Suppl 1):1-192.</Citation></Reference><Reference><Citation>Slater A, Shann F, Pearson G, Paediatric Index of Mortality (PIM) Study Group. PIM2: a revised version of the Paediatric Index of Mortality. Intensive Care Med. 2003;29(2):278-285.</Citation></Reference><Reference><Citation>Boeschoten SA, Buysse CMP, Merkus PJFM, et al. Children with severe acute asthma admitted to Dutch PICUs: a changing landscape. Pediatr Pulmonol. 2018;53(7):857-865.</Citation></Reference><Reference><Citation>Al-Eyadhy AA, Temsah M-H, Alhaboob AN, et al. Asthma changes at a pediatric intensive care unit after 10 years: observational study. Ann Thorac Med. 2015;10(4):243-248.</Citation></Reference><Reference><Citation>Hartman ME, Linde-Zwirble WT, Angus DC, Watson RS. Trends in admissions for pediatric status asthmaticus in New Jersey over a 15-year period. Pediatrics. 2010;126(4):e904-e911.</Citation></Reference><Reference><Citation>Chiang BL, Hsieh CT, Wang LC, et al. Clinical course and outcome of children with status asthmaticus treated in a pediatric intensive care unit: a 15-year review. J Microbiol Immunol Infect. 2009;42(6):488-493.</Citation></Reference><Reference><Citation>Pendergraft TB, Stanford RH, Beasley R, Stempel DA, Mclaughlin T. Seasonal variation in asthma-related hospital and intensive care unit admissions. J Asthma. 2005;42(4):265-271.</Citation></Reference><Reference><Citation>Johnston SL. Influence of viral and bacterial respiratory infections on exacerbations and symptom severity in childhood asthma. Pediatr Pulmonol. 1997;16:88-89.</Citation></Reference><Reference><Citation>Leung TF, To MY, Yeung ACM, Wong YS, Wong GWK, Chan PKS. Multiplex molecular detection of respiratory pathogens in children with asthma exacerbation. Chest. 2010;137(2):348-354.</Citation></Reference><Reference><Citation>Bizzintino J, Lee WM, Laing IA, et al. Association between human rhinovirus C and severity of acute asthma in children. Eur Respir J. 2011;37(5):1037-1042.</Citation></Reference><Reference><Citation>Kelly JT, Busse WW. Host immune responses to rhinovirus: mechanisms in asthma. J Allergy Clin Immunol. 2008;122(4):671-682.</Citation></Reference><Reference><Citation>Koninckx M, Buysse C, de Hoog M. Management of status asthmaticus in children. Paediatr Respir Rev. 2013;14(2):78-85.</Citation></Reference><Reference><Citation>Pardue Jones B, Fleming GM, Otillio JK, Asokan I, Arnold DH. Pediatric acute asthma exacerbations: evaluation and management from emergency department to intensive care unit. J Asthma. 2016;53(6):607-617.</Citation></Reference><Reference><Citation>V&#xe9;zina K, Chauhan BF, Ducharme FM. Inhaled anticholinergics and short-acting beta2-agonists versus short-acting beta2-agonists alone for children with acute asthma in hospital. Cochrane Database Syst Rev. 2014;7:CD010283.</Citation></Reference><Reference><Citation>Cheuk DKL, Chau TCH, Lee SL. A meta-analysis on intravenous magnesium sulphate for treating acute asthma. Arch Dis Child. 2005;90(1):74-77.</Citation></Reference><Reference><Citation>Mil&#xe9;si C, Boubal M, Jacquot A, et al. High-flow nasal cannula: recommendations for daily practice in pediatrics. Ann Intensive Care. 2014;4:29.</Citation></Reference><Reference><Citation>Baudin F, Buisson A, Vanel B, Massenavette B, Pouyau R, Javouhey E. Nasal high flow in management of children with status asthmaticus: a retrospective observational study. Ann Intensive Care. 2017;7:55.</Citation></Reference><Reference><Citation>Ballestero Y, De Pedro J, Portillo N, Martinez-Mugica O, Arana-Arri E, Benito J. Pilot clinical trial of high-flow oxygen therapy in children with asthma in the emergency service. J Pediatr. 2018;194:204-210.e3.</Citation></Reference><Reference><Citation>Basnet S, Mander G, Andoh J, Klaska H, Verhulst S, Koirala J. Safety, efficacy, and tolerability of early initiation of noninvasive positive pressure ventilation in pediatric patients admitted with status asthmaticus: a pilot study. Pediatr Crit Care Med. 2012;13(4):393-398.</Citation></Reference><Reference><Citation>Carson KV, Usmani ZA, Smith BJ. Noninvasive ventilation in acute severe asthma. Curr Opin Pulm Med. 2014;20(1):118-123.</Citation></Reference><Reference><Citation>Carson KV, Usmani ZA, Smith BJ. Noninvasive ventilation in acute severe asthma: current evidence and future perspectives. Curr Opin Pulm Med. 2014;20(1):118-123.</Citation></Reference><Reference><Citation>Lai CKW, de Guia TS, Kim Y-Y, et al. Asthma control in the Asia-Pacific region: the asthma insights and reality in Asia-Pacific study. J Allergy Clin Immunol. 2003;111(2):263-268.</Citation></Reference><Reference><Citation>Abu-Kishk I, Polakow-Farkash S, Elizur A. Long-term outcome after pediatric intensive care unit asthma admissions. Allergy Asthma Proc. 2016;37(6):169-175.</Citation></Reference><Reference><Citation>Hon KLE, Liu M, Zee B. Airway disease and environmental aeroallergens in eczematics approaching adulthood. Pediatr Respirol Crit Care Med. 2017;1(4):81.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>